DocDollars

Taiho Oncology, Inc.

NJ · United States · Reporting entity ID 100000146541

Total reported 2019–2025
$75.5M
#125 of 2,960 reporting companies — 0.1% of all reported industry payments
$6.10M in general payments across 26,422 records, plus $69.4M in research funding across 5,668 records.

How it breaks down

General payments $6,102,741
Research funding $69,437,840

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.

Summary

Taiho Oncology, Inc. reported $75.5M to US doctors and teaching hospitals from 2019 to 2025, ranking #125 of 2,960 reporting companies. 92% of that was research funding and 8% general payments such as consulting, speaking, food and travel. 26,422 general payment records and 5,668 research records were filed.

Common questions about Taiho Oncology, Inc.

How much has Taiho Oncology, Inc. paid US doctors?

Taiho Oncology, Inc. reported $75,540,581 to US physicians and teaching hospitals across the 2019–2025 Open Payments program years: $6,102,741 in general payments, $69,437,840 in research funding.

How does Taiho Oncology, Inc. rank among drug and device companies?

It ranks #125 of 2,960 reporting entities by total reported value, about 0.1% of all industry payments in the dataset.

Does a payment from Taiho Oncology, Inc. mean a doctor did something wrong?

No. Open Payments records transfers of value such as speaking fees, consulting, meals, travel and research funding. The data shows the relationship, not its effect on prescribing or care.